HUMA
Humacyte, Inc. · Healthcare
President, CEO, Director and 10% owner Laura E Niklason sold $1.9M of Humacyte, Inc.
Sold$1,945,509
$2.78Price
699,730Shares
−3%Stake
What HUMA did after the filing
- The stock from Thu, Dec 15 close, $2.60
- +1.2%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Jan 31 close.
Traded Tue, Dec 13. Filed Thu, Dec 15, 2:51 PM ET, during the session. Returns use the Dec 15 close and the Jan 31 close. Not investment advice.